LXR regulatory update

LXR received four U.S. patents and a notice of allowance for a U.S. patent covering its apoptotic compounds. Patent No. 5,567,425 covers methods of preventing apoptosis in cells using plant-derived inhibitors. Patent No. 5,620,888 covers cell strains that retain responsiveness to apoptosis modulating agents. Patent No. 5,624,672 covers methods of obtaining plant-derived extraacts with anti-apoptotic activity. Patent No. 5,620,885 covers a composition with anti-apoptotic activity comprised of a tissue culture media and an amount of at least one phytogenic apoptosis inhibitor effective to limit or prevent apoptosis of cells in culture. ...